The Association of the Treatment With Glucagon-Like Peptide-1 Receptor Agonist Exenatide or Insulin With Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Retrospective Observational Study

Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-015-0178-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Rationale for a Titratable Fixed-Ratio Co-Formulation of a Basal Insulin Analog and a Glucagon-Like Peptide 1 Receptor Agonist in Patients With Type 2 Diabetes

Current Medical Research and Opinion
Medicine
2018English

Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials to the Overall Type 2 Diabetes Population in the United States

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Patient Preferences for Frequency of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Injections in the Treatment of Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Glucagon-Like Peptide-1 (7-37) Augments Insulin Release in Elderly Patients With Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2001English

Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Gastroenterology
HepatologyGastroenterology
2019English

Pdb112 - Treatment and Dosing Patterns Among Patients With Type 2 Diabetes (T2d) Initiating Glucagon-Like Peptide-1 Receptor Agonists (Glp-1 Ras) in Several Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Review of Glucagon‐Like Peptide‐1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus in Patients With Chronic Kidney Disease and Their Renal Effects

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

A Retrospective Study of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Diabetes After Transplantation

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Gastrointestinal Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy